Zobrazeno 1 - 10 of 23 pro vyhledávání: '"Jean Baptiste Noury"'
3
Efficacy and safety of rituximab in myasthenia gravis: a French multicentre real‐life study
Autor: Julien Cassereau, C. Baron, D. Videt, Jean-Baptiste Noury, Armelle Magot, L. Michel, Yann Péréon, Steeve Genestet, A. Nadaj‐Pakleza, A. Dos Santos, Sandrine Wiertlewski
Publikováno v: European Journal of Neurology. 27:2277-2285
BACKGROUND AND PURPOSE Fifteen percent of patients with myasthenia gravis (MG) are refractory to conventional treatment. Case reports and a few studies show probable benefit of rituximab in these cases. Our objective was to assess the efficacy and th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0420f1df22f450fd67edcaf116d0caae
https://doi.org/10.1111/ene.14391
Zobrazit plný text záznamu
4
Exercise efficiency impairment in metabolic myopathies
Autor: Fabrice Rannou, Jean-Baptiste Noury, Pascale Marcorelles, Fabien Zagnoli, François Petit
Publikováno v: Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports, Nature Publishing Group, 2020, 10 (1), ⟨10.1038/s41598-020-65770-y⟩
Scientific Reports, 2020, 10 (1), ⟨10.1038/s41598-020-65770-y⟩
Metabolic myopathies are muscle disorders caused by a biochemical defect of the skeletal muscle energy system resulting in exercise intolerance. The primary aim of this research was to evaluate the oxygen cost (∆V’O2/∆Work-Rate) during incremen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e8761049fac9f7218520a5847f1a6c3
http://link.springer.com/article/10.1038/s41598-020-65770-y
Zobrazit plný text záznamu
5
Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins
Autor: Kouton, Ludivine, Boucraut, José, Devaux, Jérome, Rajabally, Yusuf, Adams, David, Antoine, Jean Christophe, Bourdain, Frédéric, Brodovitch, Alexandre, Camdessanché, Jean-Philippe, Cauquil, Cécile, Ciron, Jonathan, Dubard, Thierry, Echaniz-Laguna, Andoni, Grapperon, Aude-Marie, Juntas-Morales, Raul, Kremer, Laurent, Kuntzer, Thierry, Labeyrie, Céline, Lanfranco, Luca, Léger, Jean-Marc, Maisonobe, Thierry, Mavroudakis, Nicolas, Mecharles-Darrigol, Sylvie, Merle, Philippe, Noury, Jean-Baptiste, Rouaud, Violaine, Tard, Céline, Théaudin, Marie, Vallat, Jean-Michel, Viala, Karine, Attarian, Shahram, Delmont, Emilien, Ludivine, Kouton, José, Boucraut, Jérome, Devaux, Yusuf, Rajabally, David, Adams, Christophe, Antoine, Frédéric, Bourdain, Alexandre, Brodovitch, Jean-Philippe, Camdessanché, Cécile, Cauquil, Jonathan, Ciron, Thierry, Dubard, Andoni, Echaniz-Laguna, Aude-Marie, Grapperon, Raul, Juntas-Morales, Laurent, Kremer, Thierry, Kuntzer, Céline, Labeyrie, Luca, Lanfranco, Jean-Marc, Léger, Thierry, Maisonobe, Nicolas, Mavroudakis, Sylvie, Mecharles-Darrigol, Philippe, Merle, Jean- Baptiste, Noury, Violaine, Rouaud, Céline, Tard, Marie, Théaudin, Jean-Michel, Vallat, Karine, Viala, Shahram, Attarian, Emilien, Delmont
Publikováno v: Clinical Neurophysiology
Clinical Neurophysiology, 2020, 131 (4), pp.921-927. ⟨10.1016/j.clinph.2020.01.013⟩
Clinical Neurophysiology, Elsevier, 2020, 131 (4), pp.921-927. ⟨10.1016/j.clinph.2020.01.013⟩
Objective Chronic inflammatory demyelinating polyradiculoneuropathies (CIDP) with antibodies against neurofascin 155 (Nfasc155) or contactin-1 (CNTN1) have distinctive clinical features. Knowledge on their electrophysiological characteristics is stil
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::febe353ae92c2607b17789c712f49173
https://doi.org/10.1016/j.clinph.2020.01.013
Zobrazit plný text záznamu
6
A multicenter cross-sectional French study of the impact of COVID-19 on neuromuscular diseases
Autor: Vincent Laugel, Karim Wahbi, Lucie Isoline Pisella, Rabab Debs, Sarah Souvannanorath, Martial Mallaret, Thierry Kuntzer, Sylvain Nollet, Jean-Christophe Antoine, Maud Michaud, Rocío-Nur Villar-Quiles, Aude-Marie Grapperon, Sandrine Segovia-Kueny, Pascal Laforêt, Céline Tard, EL-Hadi Hammouda, Géraldine Merret, Kévin Bigaut, Juliette Svahn, Laurent Kremer, Armelle Magot, Jean-Baptiste Noury, Guillemette Beaudonnet, Louise Debergé, Aleksandra Nadaj-Pakleza, Diane Friedman, Yann Péréon, Emmanuelle Salort-Campana, Pascal Cintas, Sara Fernandes, David H. Adams, Annamaria Molon, Fanny Duval, Anthony Behin, Shahram Attarian, Frédérique Audic, Jean-Philippe Camdessanché, Isabelle Desguerre, Tanya Stojkovic, Françoise Bouhour, Marion Masingue, Guilhem Solé, Caroline Espil-Taris, Savine Vicart, Jean-Baptiste Chanson
Publikováno v: Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, 2021, 16 (1), pp.450. ⟨10.1186/s13023-021-02090-y⟩
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-9 (2021)
Orphanet Journal of Rare Diseases, BioMed Central, 2021, 16 (1), pp.450. ⟨10.1186/s13023-021-02090-y⟩
Background Due to their health condition, patients with neuromuscular diseases (NMD) are at greater risk of developing serious complications with COVID-19. The objective of this study was to analyze the prevalence of COVID-19 among NMD patients and t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::071e2f49229a47a60e0a4be3778781cb
https://hal.science/hal-03470914
Zobrazit plný text záznamu
9
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
Autor: Stella Mazurová, John W. Day, Mazen M. Dimachkie, Sónia Tizon, Anna Kostera-Pruszczyk, Tahseen Mozaffar, Joel Charrow, Chafic Karam, Ricardo Maré, Jean-Baptiste Noury, Dewi Guellec, Jorge Alonso-Pérez, Acary Souza Bulle Oliveira, Loren D M Pena, Tianyue Zhou, Sergey Illarioshkin, Nathan Thibault, Marcelo Rugiero, Can Ebru Bekircan-Kurt, Lauren Chase, Monica Sciacco, Mamatha Pasnoor, Jenny Billy, Mark Tarnopolsky, Fabien Zagnoli, Marie Wencel, Sevim Erdem-Ozdamar, Erin Hatcher, Madoka Mori, Céline Tard, Nicolas Mavroudakis, Emmanuelle Salort-Campana, Antonio Toscano, Shafeeq Ladha, Angela Genge, Ans T. van der Ploeg, Michela Guglieri, Judith Johnson, Fanny Duval, Loïc Danjoux, Christopher Hug, Robert D. Henderson, Robert Neel, Luca Solera, Aleksandra Nadaj-Pakleza, Silvia Boschi, Nizar Chahin, Maurizio Gualtiero Moggio, Peter Young, Priya S. Kishnani, Yin-Hsiu Chien, Alexandra Kautzky-Willer, Claire Questienne, Francoise Bouhour, Gabriela A Niizawa, Ekaterina Fedotova, Tiziana Enrica Mongini, Harmke A. van Kooten, Vera Malinova, Sina Helms, Shahram Attarian, Patrick Deegan, Guilhem Sole, Hamilton Cirne, Ludwig Gutmann, Kenneth I. Berger, Laura Carrera Garcia, N A M E van der Beek, Stephanie Dearmey, Suzara Souto Lopes, Anna Potulska-Chromik, Joao Lindolfo Borges, Yesim Parman, Michaela Riedl, Sergey A. Klyushnikov, Olivier Huynh-Ba, Gauthier Remiche, Paula R. Clemens, Andrea Swenson, Stephan Wenninger, Miriam Hufgard-Leitner, Eugen Mengel, Kristina An Haack, Eve Gandolfo, David Reyes-Leiva, Jean-Baptiste Davion, Chester Whitley, Young Chul Choi, Patricia Altemus, Maria Judit Molnar, Perry B. Shieh, Matthias Vorgerd, Julia B Hennermann, Cheryl Smith, Volker Straub, Lauren Noll, Pascal Laforet, Andres Nascimento Osorio, Clarisa Maxit, Anne-Catherine Aubé-Nathier, Ozlem Goker-Alpan, Olimpia Musumeci, Louisa Müller-Miny, Tarekegn Hiwot, Jacqui Langton, Christopher Nance, Daniel Natera-de Benito, Jeffrey Statland, Nicola Longo, Vivien Pautot, Zoltan Grosz, Thomas Stulnig, Matthias Boentert, Anne-Katrin Guettsches, Chong Yew Tan, Erik Ortega, Derralynn Hughes, Hacer Durmus Tekce, Mark Roberts, Lenka Linková, Amel Karaa, Hani Kushlaf, Anthony Behin, Margarida Ramos Lopes, Jordi Diaz-Manera, Alessia Pugliese, Paulo Victor Sgobbi Souza, Carrie Bailey, Jennifer B Avelar, Hirofumi Komaki, Frederic Taithe, Benedikt Schoser, Sabine Specht, Kathryn E Brown, Gerson Carvalho
Publikováno v: The Lancet Neurology, 20(12), 1012-1026. Lancet Publishing Group
Summary Background Pompe disease is a rare, progressive neuromuscular disorder caused by deficiency of acid α-glucosidase (GAA) and accumulation of lysosomal glycogen. We assessed the safety and efficacy of avalglucosidase alfa, a recombinant human
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::070f1f6f1e025674e4ced58aa9218fbf
http://hdl.handle.net/11570/3218654
Zobrazit plný text záznamu
10
The ratio of maximal handgrip force and maximal cycloergometry power as a diagnostic tool to screen for metabolic myopathies
Autor: Jean-Baptiste Noury, François Petit, Cédric Le Maréchal, Pascale Marcorelles, Fabien Zagnoli, Fabrice Rannou
Publikováno v: Scientific Reports
Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.8865. ⟨10.1038/s41598-020-65797-1⟩
Scientific Reports, Vol 10, Iss 1, Pp 1-7 (2020)
Metabolic myopathies comprise a diverse group of inborn errors of intermediary metabolism affecting skeletal muscle, and often present clinically as an inability to perform normal exercise. Our aim was to use the maximal mechanical performances achie
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2688f4c25a5a86355183b4d3c69f0e1
https://www.hal.inserm.fr/inserm-02870506/document
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje